Compare DFLI & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DFLI | BFRI |
|---|---|---|
| Founded | 2020 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.8M | 16.3M |
| IPO Year | 2021 | 2021 |
| Metric | DFLI | BFRI |
|---|---|---|
| Price | $1.16 | $1.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $3.25 | $2.75 |
| AVG Volume (30 Days) | 345.5K | ★ 547.3K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 67.70 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $58,630,000.00 | $41,705,000.00 |
| Revenue This Year | N/A | $14.36 |
| Revenue Next Year | $51.17 | $16.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 15.77 | 11.75 |
| 52 Week Low | $0.26 | $0.57 |
| 52 Week High | $5.15 | $1.60 |
| Indicator | DFLI | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 39.81 | 69.87 |
| Support Level | $1.11 | $0.71 |
| Resistance Level | $1.46 | N/A |
| Average True Range (ATR) | 0.07 | 0.10 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 24.97 | 73.81 |
Dragonfly Energy Holdings Corp is engaged in the design, assembly, and sale of lithium-ion batteries, mainly lithium iron phosphate (LFP) batteries, for applications in recreational vehicles, marine, industrial, and other markets. The company operates through two segments: direct-to-consumer (DTC), which sells Battle Born branded batteries, and OEM, which supplies Dragonfly branded batteries to original equipment manufacturers.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.